STABILITY OF CELL-SIZE AND NUCLEOLAR SIZE IN LEWY BODY CONTAINING NEURONS OF SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE

被引:36
|
作者
GERTZ, HJ [1 ]
SIEGERS, A [1 ]
KUCHINKE, J [1 ]
机构
[1] HUMBOLDT UNIV BERLIN,DEPT ANAT,D-10117 BERLIN,GERMANY
关键词
LEWY BODY; SUBSTANTIA NIGRA; NUCLEOLAR VOLUME; MORPHOMETRY; PARKINSONS DISEASE;
D O I
10.1016/0006-8993(94)91257-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Samples of 9 brains of autopsied patients suffering from Parkinson's disease were examined. In H gr E stained 20 mu m thick sections of substantia nigra 10 Lewy body containing and 20 unaffected pigmented nerve cells of substantia nigra per case were measured for size of the perikarya and nucleolar size utilizing an interactive image processing unit. In affected cells the size of Lewy bodies was measured too. There was no significant difference in the size of the perikarya and nucleolar size between affected and unaffected cells. In Lewy body bearing cells nucleolar size was not correlated with the size of the Lewy bodies. There was a significant negative correlation between nucleolar size of substantia nigra neurons and the duration of the disease. Since nucleolar volume can serve as indicator of RNA synthesis of a cell, Lewy bodies do not seem to disturb nerve cell metabolism.
引用
收藏
页码:339 / 341
页数:3
相关论文
共 24 条
  • [1] MEAN VOLUME OF PIGMENTED NEURONS IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE
    MOLLER, A
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 85 : 37 - 39
  • [2] IRON HISTOCHEMISTRY OF THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE
    MORRIS, CM
    EDWARDSON, JA
    NEURODEGENERATION, 1994, 3 (04): : 277 - 282
  • [3] IS THE VULNERABILITY OF NEURONS IN THE SUBSTANTIA-NIGRA OF PATIENTS WITH PARKINSONS-DISEASE RELATED TO THEIR NEUROMELANIN CONTENT
    KASTNER, A
    HIRSCH, EC
    LEJEUNE, O
    JAVOYAGID, F
    RASCOL, O
    AGID, Y
    JOURNAL OF NEUROCHEMISTRY, 1992, 59 (03) : 1080 - 1089
  • [4] RELATIVE SPARING IN PARKINSONS-DISEASE OF SUBSTANTIA-NIGRA DOPAMINE NEURONS CONTAINING CALBINDIN-D28K
    YAMADA, T
    MCGEER, PL
    BAIMBRIDGE, KG
    MCGEER, EG
    BRAIN RESEARCH, 1990, 526 (02) : 303 - 307
  • [5] REDUCED AND OXIDIZED GLUTATHIONE IN THE SUBSTANTIA-NIGRA OF PATIENTS WITH PARKINSONS-DISEASE
    SOFIC, E
    LANGE, KW
    JELLINGER, K
    RIEDERER, P
    NEUROSCIENCE LETTERS, 1992, 142 (02) : 128 - 130
  • [6] NEUROMELANIN-CONTAINING NEURONS OF THE SUBSTANTIA-NIGRA ACCUMULATE IRON AND ALUMINUM IN PARKINSONS-DISEASE - A LAMMA STUDY
    GOOD, PF
    OLANOW, CW
    PERL, DP
    BRAIN RESEARCH, 1992, 593 (02) : 343 - 346
  • [7] PATHOLOGICAL-CHANGES IN DENDRITES OF SUBSTANTIA-NIGRA NEURONS IN PARKINSONS-DISEASE - A GOLGI-STUDY
    PATT, S
    GERTZ, HJ
    GERHARD, L
    CERVOSNAVARRO, J
    HISTOLOGY AND HISTOPATHOLOGY, 1991, 6 (03) : 373 - 380
  • [8] NEURONAL HYPERTROPHY IN THE PARS RETICULATA OF THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE
    NEAL, JW
    PEARSON, RCA
    COLE, G
    POWELL, TPS
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1991, 17 (03) : 203 - 206
  • [9] NEUROFILAMENT MESSENGER-RNA IS REDUCED IN PARKINSONS-DISEASE SUBSTANTIA-NIGRA PARS-COMPACTA NEURONS
    HILL, WD
    ARAI, M
    COHEN, JA
    TROJANOWSKI, JQ
    JOURNAL OF COMPARATIVE NEUROLOGY, 1993, 329 (03) : 328 - 336
  • [10] THE COMBINED METHOD OF TRANSPLANTATION OF FETAL SUBSTANTIA-NIGRA AND STEREOTAXIC THALAMOTOMY FOR PARKINSONS-DISEASE
    WU, CY
    DEZHOU, M
    BAO, XF
    ZHANG, QL
    SUN, W
    LI, FZ
    ZHAO, JJ
    BRITISH JOURNAL OF NEUROSURGERY, 1994, 8 (06) : 709 - 716